Skip to main content
Caplight Logo









CureSkin

CureSkin

Private
BangaloreHealthcare & Life Scienceshttps://cureskin.com/

Last Round

Series B

Mar 13, 2024

Total Funding Raised

$26.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CureSkin is a health care technology company that provides an AI-powered dermatology platform offering personalized skincare and haircare treatment plans, dermatologist consultations, and home-delivered care products.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Fashion & Beauty, Medical AI, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

teledermatologyskincare appAI dermatologyD2C skincarepersonalized skincarehair care appbeauty techskin analysishair analysistelemedicinehealth techacne treatmenthair loss treatmentmedical AIdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureSkin Comparables

Compare CureSkin with similar companies based on industry and business-model similarity.

CureSkin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Traya
82%
MDalgorithms
77%
Clinikally
77%

CureSkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 13, 2024
Series AMar 7, 2022
SeedJan 28, 2020
SeedAug 22, 2017

Key People

Founding team and executive leadership

Ramakrishna R

Co-Founder CTO

Founding Team

Guna Kakulapati

Co-Founder CEO

Founding Team

Jignesh Jain

Chief Financial Officer

Executive Team

CureSkin Investors

Notable investors and investment history

CureSkin investors
InvestorRounds
Khosla VenturesSeed, Series B
Taver Capital PartnersSeed
SenseAISeries A
Sharrp VenturesSeries A, Series B
Y CombinatorSeed
SenseAI VenturesSeries A, Seed
Heartbeat LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 89% MoM, reaching 70.7K.

  • Jun 20, 2026

    Monthly visitors increased 37% MoM.

CureSkin Filings

Explore SEC and related filing metadata, where available.

CureSkin filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CureSkin's valuation, stock price, and market status.

Is CureSkin a public or private company?

CureSkin is a private company.

What is the current stock price of CureSkin?

CureSkin is a private company with no public stock price. No recent secondary market data is available.

How much is CureSkin worth (valuation)?

Valuation information for CureSkin is not publicly available.

Can I buy CureSkin stock?

CureSkin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CureSkin's last funding round?

CureSkin's most recent funding round was Series B on March 13, 2024.

Who are the main investors in CureSkin?

Key investors in CureSkin include SenseAI Ventures, HealthQuad, JSW Ventures.

Will CureSkin IPO soon?

No public IPO plans have been announced for CureSkin.

How can I track CureSkin secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureSkin's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range207
Year Founded2017
Last FundingMar 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?